Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ANRO | ALTO NEUROSCIENCE INC | $531.23M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $3.74B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SNTI | SENTI BIOSCIENCES INC | $32.86M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PEPG | PEPGEN INC | $379.49M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TRVI | TREVI THERAPEUTICS INC | $1.59B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CYRX | CRYOPORT INC | $462.64M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VREX | VAREX IMAGING CORP | $494.56M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RCUS | ARCUS BIOSCIENCES INC | $2.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DYN | DYNE THERAPEUTICS INC | $2.79B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CTMX | CYTOMX THERAPEUTICS INC | $720.10M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IRD | OPUS GENETICS INC | $147.58M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NXTC | NEXTCURE INC | $29.80M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DD | DUPONT DE NEMOURS INC | $16.95B | 3.04% | -87.50% | $0.4100 | $1.23 | 66% | 3 | ||
| OVID | OVID THERAPEUTICS INC | $110.38M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| WYFI | WHITEFIBER INC | $576.96M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| DNLI | DENALI THERAPEUTICS INC | $2.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ENOV | ENOVIS CORP | $1.49B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BEP | BROOKFIELD RENEWABLE PARTNERS LP | $7.92B | 1.34% | -128.00% | $0.3730 | $0.37 | 32% | 2 | ||
| ALMS | ALUMIS INC | $1.19B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ORKA | ORUKA THERAPEUTICS INC | $1.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KSCP | KNIGHTSCOPE INC | $56.05M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CLYM | CLIMB BIO INC | $315.01M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MLYS | MINERALYS THERAPEUTICS INC | $2.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $131.93M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TTAN | SERVICETITAN INC | $9.84B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EVEX | EVE HOLDING INC | $1.63B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RAPT | RAPT THERAPEUTICS INC | $943.00M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MGX | METAGENOMI INC | $64.20M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ANGO | ANGIODYNAMICS INC | $555.37M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JMIA | JUMIA TECHNOLOGIES AG | $1.48B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TDS | TELEPHONE & DATA SYSTEMS INC | $4.38B | 0.32% | -14.70% | $0.0400 | $0.12 | 5% | 1 | 2025-12-30 | |
| EVTL | VERTICAL AEROSPACE LTD | $567.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.57B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMEA | BIOMEA FUSION INC | $96.86M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RNAC | CARTESIAN THERAPEUTICS INC | $215.57M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PYXS | PYXIS ONCOLOGY INC | $249.06M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RZLT | REZOLUTE INC | $187.31M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VIR | VIR BIOTECHNOLOGY INC | $901.53M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AMPL | AMPLITUDE INC | $1.47B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NOMD | NOMAD FOODS LTD | $1.85B | 4.06% | 36.40% | $0.1700 | $0.51 | 78% | 0 | ||
| SI | SHOULDER INNOVATIONS INC | $337.87M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| GLXY | GALAXY DIGITAL INC | $9.50B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| MNPR | MONOPAR THERAPEUTICS | $477.60M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VYX | NCR VOYIX CORP | $1.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NKLR | TERRA INNOVATUM GLOBAL NV | $369.08M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| ZURA | ZURA BIO LTD | $267.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PRQR | PROQR THERAPEUTICS NV | $244.50M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RWT | REDWOOD TRUST INC | $713.22M | 9.59% | -87.80% | $0.1800 | $0.54 | 95% | 2 | 2025-12-23 | 2025-12-30 |
| PRCH | PORCH GROUP INC | $1.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AVBP | ARRIVENT BIOPHARMA INC | $954.01M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SSTI | SOUNDTHINKING INC | $100.70M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MPLT | MAPLIGHT THERAPEUTICS INC | $923.34M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $337.06M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| Q | QNITY ELECTRONICS INC | $16.44B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| CARL | CARLSMED INC | $335.07M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| GLOO | GLOO HOLDINGS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TBPH | THERAVANCE BIOPHARMA INC | $888.29M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ICHR | ICHOR HOLDINGS LTD | $603.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| XNCR | XENCOR INC | $1.18B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PSN | PARSONS CORP | $6.57B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SMWB | SIMILARWEB LTD | $636.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IMTX | IMMATICS NV | $1.23B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OTLY | OATLY GROUP AB | $340.15M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $428.61M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NTGR | NETGEAR INC | $683.65M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $456.20M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PASG | PASSAGE BIO INC | $30.04M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FBRX | FORTE BIOSCIENCES INC | $291.50M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FANG | DIAMONDBACK ENERGY INC | $42.71B | 2.68% | 27.40% | $1.0000 | $4.00 | 60% | 4 | ||
| MNMD | MIND MEDICINE (MINDMED) INC | $1.21B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RIOT | RIOT PLATFORMS INC | $5.01B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LFMD | LIFEMD INC | $164.62M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VNDA | VANDA PHARMACEUTICALS INC | $392.99M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TVRD | TVARDI THERAPEUTICS INC | $39.40M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IAC | IAC INC | $3.00B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OM | OUTSET MEDICAL INC | $71.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $917.99M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BRSL | BRIGHTSTAR LOTTERY PLC | $3.08B | 3.80% | 250.00% | $0.2000 | $0.60 | 75% | 0 | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| XFOR | X4 PHARMACEUTICALS INC | $324.39M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPWH | SPORTSMAN's WAREHOUSE HOLDINGS INC | $56.57M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.